[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![doepke_michel Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1350720698591936515.png) Michel Doepke [@doepke_michel](/creator/twitter/doepke_michel) on x 4916 followers
Created: 2025-07-21 12:01:52 UTC

$URGN Announces Five-Year Long-Term Extension Study of the OPTIMA II Trial Demonstrates Long-Term Durability of Response to ZUSDURI in Patients with Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1947265768560664902/c:line.svg)

**Related Topics**
[$urgn](/topic/$urgn)

[Post Link](https://x.com/doepke_michel/status/1947265768560664902)